MTC's Technology Transformation Symposium Series Four symposiums. Four critical technology topics. One statewide conversation.
The Maryland Tech Council is taking a new approach to its Technology Transformation Conference with a series of four individual Technology Symposiums throughout the year. Each half-day event will spotlight a critical area shaping the future of technology and innovation, bringing together industry experts to share insights, explore emerging trends, and discuss the challenges and opportunities transforming their respective sectors. Technology Symposium Series: AI and Biotech Wednesday, November 18, 2026 | 8:30 AM – 1:30 PM Maryland Jockey Club | Laurel, Maryland
The first symposium will explore the growing influence of artificial intelligence on healthcare and biotechnology. This half-day program will feature keynote presentations, expert panel discussions, and a student and employer Q&A session focused on the ways AI is advancing innovation, shaping the future of healthcare, and creating new opportunities across the life sciences industry. |
|
Take a Look at the Agenda for the Technology Symposium: AI and BioTech |
|
|
|
Registration, Coffee, and Networking |
|
|
|
Welcome and Opening Remarks |
|
|
|
| Panel Session 1 Beyond the AI Hype: Creating, Capturing & Realizing Value in Biotech
AI is reshaping biotech and life sciences, creating new possibilities across our industry. But an important question remains: Where will AI create durable economic value, who will capture that value, and how will the market ultimately value it?
For investors, founders and executives, we'll look beyond simply who is "using AI" to explore what AI actually enables: faster development, greater capital efficiency, better outcomes, stronger competitive positioning and ultimately, greater enterprise value.
MODERATOR: Jennifer Gallino, Associate Vice President, Rockefeller Global Investment Management
PANELISTS:
- Adam Konopolsky, Managing Director, Blackstone
- Caroline Popper, MD, JD, and MPH, Corporate Attorney, Nemphos Braue, Founder, Popper and Company
- David M. Sotsky, CPFA , Private Advisor, Vice President, Rockefeller Global Family Office
|
|
|
|
| Panel Session 2 AI in Action: What's Actually Working, What Isn't, and Why
Where is AI delivering real results across the life sciences, and where has it fallen short? This panel brings together leaders applying AI in areas such as drug discovery, business operations, and legal and regulatory oversight. They will share real-world successes, challenges, and lessons on moving AI from pilot projects to productions while managing risk.
MODERATOR: Steve Navarro, President, Mind Over Machines
PANELISTS:
- Kim Cato, VP, IT, Customer Channels, Thermo Fisher Scientific
- Robert Hsiao, Head of Beijing AI Center and Discovery, AstraZeneca
- Alex Moylan, AI Attorney, Baker Donelson
- Danielle Seiler, Director Proof of Concept Lead, U.S. Pharmacopeia
|
|
|
|
| The Art of the Possible: Reimagining Work with Human + AI Teams
Subject Matter Expert Tim Kulp, Chief Innovation Officer, Mind Over Machines
What becomes possible when we rethink how work gets done and who can help us do it? This session explores three foundations for creating real value with AI: understanding the work, managing context, and redesigning the team. |
|
Sponsorship Opportunities
Showcase your organization as a supporter of Maryland’s technology community through sponsorship opportunities for the AI and BioTech Symposium and the full symposium series.
Connect your brand with industry leaders and professionals while gaining visibility among those shaping the future of technology and innovation. For sponsorship details, contact Amy Speck at Amy@mdtechcouncil.com. |
|
|
|
|
